A 8 weeks, multi-center, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Agrimonia pilosa extract powder on improvement of Liver function

Wonkwang University, Gwangju Medical Center0 sites100 target enrollmentTBD

Overview

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional Study

Sex

All

Sponsor

Wonkwang University, Gwangju Medical Center

•1\) Adult men and women aged 19 years or older and 75 years or less at the screening test
•2\) Participants whose blood ALT level within 46\~135 U/L
•3\) A person who, after hearing and fully understanding the detailed explanation of this trial, voluntarily decides to participate and agrees in writing to comply with the precautions

•1\) Acute or chronic hepatitis patients or individuals with Hepatitis B or Hepatitis C virus infection
•2\) Individuals with liver cirrhosis, liver cancer, or signs suggestive of liver cancer.
•3\) Individuals with a BMI of less than 18\.5 kg/m^2 or greater than 35 kg/m^2 at screening
•4\) Those who have taken liver function improving drugs and health functional foods within 1 month prior to screening
•5\) Those with a history of clinically significant hypersensitivity to Agrimonia pilosa
•6\) Pregnant or lactating women
•7\) Women of childbearing potential who do not accept the practice of adequate contraception
•8\) Those who participated in other clinical trials within 3 months prior to screening
•9\) A person who is judged unsuitable for participation in the study by the director of the study due to diagnostic test results and other reasons

Not specified